Medinotec (MDNC) Cash from Investing Activities (2022 - 2026)
Medinotec (MDNC) posted Cash from Investing Activities of -$40350.0 for Q2 2026, down 3097.77% on a QoQ basis from $1346.0 in Q1 2025.
Medinotec (MDNC) Cash from Investing Activities (2022 - 2026) Analysis & Trends
Medinotec's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$40350.0 for Q2 2026.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$40350.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$123308.0 (changed N/A YoY) and the FY2026 annual result came in at -$1363.0, up 98.47% from the prior year.
- Cash from Investing Activities was -$40350.0 for Q2 2026 at Medinotec, down from $1346.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $121562.0 in Q1 2023 and bottomed at -$621785.0 in Q4 2022.
- A 5-year average of -$67151.5 and a median of -$11678.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 234.24% — and 2024, when it sank 90.97%.
- Medinotec's Cash from Investing Activities stood at -$621785.0 in 2022, then jumped by 119.55% to $121562.0 in 2023, then sank by 159.74% to -$72626.0 in 2024, then soared by 101.85% to $1346.0 in 2025, then tumbled by 3097.77% to -$40350.0 in 2026.
- Business Quant data shows MDNC's Cash from Investing Activities at -$40350.0 in Q2 2026, $1346.0 in Q1 2025, and -$72626.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | -40,350.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -40,350.00 |
| May 31, 2026 | -40,350.00 |
| Feb 28, 2025 | 1,346.00 |
| Feb 28, 2025 | 1,346.00 |
| Nov 30, 2024 | -72,626.00 |
| Nov 30, 2024 | -72,626.00 |
| Aug 31, 2024 | -11,678.00 |
| Aug 31, 2024 | -11,678.00 |
| May 31, 2024 | -6,055.00 |
| May 31, 2024 | -6,055.00 |
| Feb 29, 2024 | 10,976.00 |
| Feb 29, 2024 | 10,976.00 |
| Feb 28, 2023 | 121,562.00 |
| Feb 28, 2023 | 121,562.00 |
| Nov 30, 2022 | -621,785.00 |
| Nov 30, 2022 | -621,785.00 |
| Aug 31, 2022 | -9,407.00 |
| Aug 31, 2022 | -9,407.00 |
| May 31, 2022 | -20,093.00 |
| May 31, 2022 | -20,093.00 |